TAKE A CLOSER LOOK AT

WIXELA INHUB®

WIXELA INHUB from VIATRISTM offers your appropriate patients with asthma or COPD a new generic ICS/LABA therapy option.1,2 WIXELA INHUB is NOT indicated for the relief of acute bronchospasm.

Only the 250/50 mcg strength is indicated for COPD.
Available in the same 3 dosage strengths as ADVAIR DISKUS® :

Wixela Inhub 100/50 mcg (fluticasone propionate and salmeterol inhalation powder, USP) product image
Wixela Inhub 100/50 mcg
(fluticasone propionate and salmeterol inhalation powder, USP)
Wixela Inhub 250/50 mcg (fluticasone propionate and salmeterol inhalation powder, USP) product image
Wixela Inhub 250/50 mcg
(fluticasone propionate and salmeterol inhalation powder, USP)
Wixela Inhub 500/50 mcg (fluticasone propionate and salmeterol inhalation powder, USP) product image
Wixela Inhub 500/50 mcg
(fluticasone propionate and salmeterol inhalation powder, USP)

WIXELA INHUB contains the same active ingredients as ADVAIR DISKUS that have been shown to both control symptoms in asthma patients and improve lung function all day in COPD patients.3